Study identifies novel mechanism by which tumors can resist cancer immunotherapyNews-Medical.netA Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive … Continue reading
News-Medical.netNew gene therapy for blindness may soon be realityNews-Medical.netPatients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to resea… Continue reading
CRISPR Therapeutics Highlights New Additions to Portfolio of Allogeneic CRISPR-based CAR-T Therapies at SITC …NasdaqThese data were presented during the Society for Immunotherapy in Cancer 32nd Annual Meeting during the Cellular Therapy Approaches Tr… Continue reading
CRISPR Therapeutics Highlights New Additions to Portfolio of Allogeneic CRISPR-based CAR-T Therapies at SITC …GlobeNewswire (press release)ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a g… Continue reading
Xconomy |
Juno Dissects ROCKET Deaths, Will Aim Better CAR–T at Leukemia
Xconomy CAR-T therapy has shown great promise, knocking out otherwise untreatable cancer, at least temporarily, in dozens of adults and kids with certain types of leukemia and lymphoma. The most promising form of CAR-T uses a patient’s own T cells, drawn from … |
MD Magazine |
Gene Therapy Recovers LCA Patient Vision
MD Magazine The tested gene therapy, voretigene neparvovec (Luxturna) from Spark Therapeutics, is currently under FDA review for potential approval by January 2018. An injection therapy, it uses a genetically-modified version of a harmless virus that’s been … |